BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18573819)

  • 21. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.
    Mikulkova Z; Praksova P; Stourac P; Bednarik J; Strajtova L; Pacasova R; Belobradkova J; Dite P; Michalek J
    Cell Immunol; 2010; 262(2):75-9. PubMed ID: 20219185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
    Krakauer M; Sorensen PS; Sellebjerg F
    J Neuroimmunol; 2006 Dec; 181(1-2):157-64. PubMed ID: 17081623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory and naïve B-cell subsets in patients with multiple sclerosis.
    Niino M; Hirotani M; Miyazaki Y; Sasaki H
    Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms.
    Duftner C; Seiler R; Klein-Weigel P; Göbel H; Goldberger C; Ihling C; Fraedrich G; Schirmer M
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1347-52. PubMed ID: 15845908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a.
    Dressel A; Mirowska-Guzel D; Gerlach C; Weber F
    Acta Neurol Scand; 2007 Sep; 116(3):164-8. PubMed ID: 17714329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
    Debes GF; Bonhagen K; Wolff T; Kretschmer U; Krautwald S; Kamradt T; Hamann A
    J Virol; 2004 Jul; 78(14):7528-35. PubMed ID: 15220427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-box 21 transcription factor is responsible for distorted T(H)2 differentiation in human peripheral CD4+ T cells.
    Kaminuma O; Kitamura F; Miyatake S; Yamaoka K; Miyoshi H; Inokuma S; Tatsumi H; Nemoto S; Kitamura N; Mori A; Hiroi T
    J Allergy Clin Immunol; 2009 Apr; 123(4):813-23.e3. PubMed ID: 19348920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD28nullCD4+ T cells--characterization of an effector memory T-cell population in patients with rheumatoid arthritis.
    Fasth AE; Cao D; van Vollenhoven R; Trollmo C; Malmström V
    Scand J Immunol; 2004; 60(1-2):199-208. PubMed ID: 15238090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomonitoring measures in relapsing-remitting multiple sclerosis.
    Matsui M; Araya SI; Wang HY; Matsushima K; Saida T
    J Neuroimmunol; 2004 Mar; 148(1-2):192-9. PubMed ID: 14975601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
    Broux B; Pannemans K; Zhang X; Markovic-Plese S; Broekmans T; Eijnde BO; Van Wijmeersch B; Somers V; Geusens P; van der Pol S; van Horssen J; Stinissen P; Hellings N
    J Autoimmun; 2012 Feb; 38(1):10-9. PubMed ID: 22123179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.
    Chiarini M; Sottini A; Ghidini C; Zanotti C; Serana F; Rottoli M; Zaffaroni M; Bergamaschi R; Cordioli C; Capra R; Imberti L
    Mult Scler; 2010 Feb; 16(2):218-27. PubMed ID: 20007428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.